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Summary
BACKGROUND: We evaluated the prospectively collected
data about the incidence of early peri- and postoperative
complications, and potential risk factors for adverse out-
comes after living kidney donation in Switzerland.
METHODS: Peri- and postoperative events were prospec-
tively recorded on a questionnaire by the local transplant
teams of all Swiss transplant centres and evaluated by the
Swiss Organ Living Donor Health Registry. Complications
were classified according to the Clavien grading system. A
total of 1649 consecutive donors between 1998 and 2015
were included in the analysis.
RESULTS: There was no perioperative mortality ob-
served. The overall complication rate was 13.5%. Major
complications defined as Clavien ≥3 occurred in 2.1%
of donors. Obesity was not associated with any compli-
cations. Donor age >70years was associated with major
complications (odds ratio [OR] 3.99) and genitourinary
complications (urinary tract infection OR 5.85; urinary re-
tention OR 6.61). There were more major complications
observed in donors with laparoscopic surgery versus open
surgery (p = 0.048), but an equal overall complication rate
(p = 0.094).
CONCLUSION: We found a low rate of major and minor
complications, independent of surgical technique, after liv-
ing donor nephrectomy. There was no elevated complica-
tion rate in obese donors. In contrast, elderly donors >70
years had an elevated risk for perioperative complications.
Key words: living donor nephrectomy, early complica-
tions, kidney transplantation, morbidity, donor registry
Introduction
Kidney transplantation is considered the optimal treatment
in patients with end-stage renal disease. Despite efforts to
increase the number of deceased donors, the demand for
renal transplantation exceeds the available organs by far.
This shortage has led to an increase of kidney transplan-
tations from living donors during the last decades. Living
kidney donation (LKD) in Switzerland has been performed
since the beginning of kidney transplantation in 1966. The
percentage of kidney transplants from living donors has
steadily increased and nowadays accounts for about one
third of all donors in Switzerland [1, 2]. Living kidney do-
nation has several advantages for the kidney recipient like
improved long-term allograft survival, pre-emptive trans-
plantation or shorter time on dialysis and therefore im-
proved patient survival [3–5]. Ethical concerns about this
procedure have existed since the very beginning of liv-
ing kidney transplantation (LKT), as a healthy individual
is exposed to the risk of a surgical procedure without a
direct health benefit for him- or herself. In addition, se-
lection criteria of living kidney donors have changed over
time and nowadays some elderly, overweight or hyperten-
sive donors are also accepted, with higher short- and long-
term risks of complications [6, 7]. Therefore, detailed in-
formation about the risk of LKD is crucial to justify this
procedure. Potential future donors must be better informed
so that they fully understand the potential risk and long-
term consequences associated with such a procedure. De-
spite the increase of LKD during past decades there are on-
ly a few articles reporting prospectively collected cohort
data about perioperative, short-term and long-term compli-
cations after living donor nephrectomy [8–11]. Owing to
the complete lack of such data in the early nineties, the
Swiss Organ Living Donor Health Registry (SOL-DHR)
was founded in 1993 with the aim to prospectively assess
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the incidence of complications of LKD and to identify risk
profiles associated with unfavourable outcomes [12]. We
analysed the data from the SOL-DHR in terms of the inci-
dence of early peri- and postoperative complications after
LKD and potential risk factors for adverse outcome.
Materials and methods
Data collection
Since 1993, all living kidney donors in Switzerland have
been registered in a national registry, the SOL-DHR. Ini-
tially, all six kidney transplantation centres agreed to in-
clude all donors in the SOL-DHR and since 2007 it has
been mandatory in accordance with Swiss transplantation
law to provide a lifelong follow-up of all living donors in
Switzerland. Since 1998, all six Swiss transplant centres
(Basel, Berne, Geneva, Lausanne, St Gallen, Zurich) report
the peri- and postoperative surgical complications to the
SOL-DHR by filling in a questionnaire. For this study all
patients who are registered in the SOL-DHR database with
available data on the peri- and postoperative surgical com-
plications from January 1998 until December 2015 were
included.
Preoperative data consisted of height, weight, blood pres-
sure, body mass index (BMI), sex, age and any medication.
Peri- and postoperative events were reported by the local
transplant team and recorded in a questionnaire (appendix
1, available in a separate file for downloading) consisting
of following data: surgical complications, wound infec-
tions, urinary tract infections (UTI), other infections, uri-
nary retention, deep vein thrombosis, pulmonary em-
bolism, psychological complications, arterial hypertension
after surgery on at least 2 consecutive days, need for blood
transfusion, length of hospital stay, analgesic medication at
discharge, other complications, side of nephrectomy, surgi-
cal technique, re-operation during the first 3 months, over-
all pain perception on visual analogue scale. The question-
naire was completed at the time of the donor discharge
after nephrectomy and sent to the SOL-DHR. In addition,
early complications during the first 3 months after surgery,
which were reported to the SOL-DHR by the donors’ gen-
eral practitioners or by the donors themselves, were includ-
ed after evaluation and confirmation by the medical staff
of the SOL-DHR.
Every early complication observed in a donor was clas-
sified by the medical board of the SOL-DHR according
to the Dindo-Clavien grading system for surgical compli-
cations [13]. Grade 1 is any deviation from the normal
postoperative course that requires no treatment other than
antiemetic, antipyretic, diuretic or analgesic medication,
electrolytes or physiotherapy. Grade 2 requires medical
therapy other than that allowed for in Grade 1. Grade 3
requires endoscopic, surgical or radiological interventions
under local (3a) or general anaesthesia (3b). Grade 4 signi-
fies failure in at least one organ system and is life threat-
ening, requiring intensive care. Grade 5 equals death of
the patient. Each complication was counted separately: one
donor could present with several complications indepen-
dent of each other, so each donor could contribute several
times to a complication subtype.
During the study period, five different surgical techniques
for LKD were performed. Classic open nephrectomy
(OLDN) was used in the early period, fully laparoscopic
nephrectomy (LDN) was introduced in 1997, hand-assisted
laparoscopic nephrectomy (HLDN) in 1998, mini-incision
pararectal nephrectomy (MLDN) in 1999 and retroperito-
neoscopic nephrectomy (RLDN) in 2001. For the analy-
sis of the influence of surgical technique on complications,
two surgical categories were defined, either open (OLDN
+ MLDN) or laparoscopic (LDN, HLDN and RLDN).
The protocol was approved by the institutional ethics com-
mittees of the University of Basel, University of Berne,
University of Geneva, University of Lausanne, Kanton-
sspital St. Gallen and University of Zurich, Switzerland.
Statistical analysis
We used JMP software version 12 (SAS Institute Inc.,
Cary, NC) for statistical analysis. Categorical data as given
as count (percentage) and analysed with Pearson’s chi-
square or Fisher’s exact test. Continuous data are given as
median (interquartile range [IQR]) and were analysed with
the Wilcoxon or Student’s t-test as appropriate. Odds ratios
were calculated by comparing the frequency of the investi-
gated outcome between two groups. As only three compar-
isons for each outcome were made, no correction for multi-
ple testing was considered necessary. A p-value <0.05 was
taken to indicate statistical significance.
Results
Donor characteristics
From January 1998 to December 2015, 1694 living kidney
donors were registered in the SOL-DHR. Data on peri-
and postsurgical complications were available in 1649 of
kidney donors (97.4%). Baseline characteristic are sum-
marised in table 1. Duration of the hospital stay changed
significantly over time, from a median of 10 days (IQR
8.25–11.75) in 1998 to 5 days (IQR 4–6) after 2012 (p
<0.0001). During the study period, there were five differ-
ent surgical types of donor nephrectomy performed (table
2). No perioperative mortality was observed during the
study period. Overall there were 254 complications in 222
patients (13.5%) reported to the SOL-DHR and sum-
marised in table 3. The overall rate of donors with severe
complications (Clavien 3 and 4) was 2.1% (n = 34). Twen-
ty donors needed a reoperation, 17 during the early postop-
erative period and 3 donors after discharge and within the
first 3 months after nephrectomy. In eight donors reopera-
tion was due to bleeding complications (seven with severe
retroperitoneal hematoma and one with a lesion of the in-
ternal iliac artery). Other reasons for reoperation were her-
nia (n = 2), bowel perforation (n = 2) and mechanical ileus
(n = 2). Conversion to OLDN was necessary in ten donors
(seven LDN, one HLDN and in two RLDN). The inci-
dence of severe complications (Clavien 3 and 4) was more
frequent in donors undergoing laparoscopic techniques for
nephrectomy than with open surgery (p = 0.048), but the
overall complication rate, as well as the incidence of reop-
eration, were similar between the two surgical categories
(p = 0.094 and p = 0.15 respectively). Age was significant-
ly associated with severe complications (Clavien 3 and 4)
when comparing donors aged >70 years with donors aged
<50 years (OR 3.99, 95% CI 1.37 -11.67) (table 4). There
was no association for donors with higher BMI (BMI <30
kg/m2 vs 30–35 kg/m2, p = 0.41; BMI <30 kg/m2 vs BMI
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>35 kg/m2, p = 0.52). In total, 17 donors (1.03%) received
blood transfusions because of significant blood loss.
Grade 2 complications were mainly infectious diseases
(see table 3). UTI was significantly associated with older
age (table 5). There were no associations between the in-
cidence of wound infections and a higher BMI (BMI <30
kg/m2 vs BMI >30 kg/m2, p = 0.54) or between open ver-
sus laparoscopic nephrectomy (p = 0.76). Urinary reten-
tion was more frequently observed in male than in female
donors (17/559 vs 11/1062, p = 0.008) and in donors aged
>70 years compared to donors aged <50 years (OR 6.61,
95% CI 2.29–19.11) (table 6). At the day of discharge
66.8% of donors still took some analgesic drugs.
During the postoperative phase 73 donors (4.4%) had hy-
pertensive blood pressure readings (>140/90 mm Hg) on at
least two consecutive days. Of these, 49 donors were al-
ready treated for hypertension. For 11 donors, blood pres-
sure normalised during follow-up; 13 donors had persistent
hypertension and had to start antihypertensive medication.
Psychological disorders (depression, anxiety) were ob-
served in 44 donors (2.7%). There was no centre effect for
Table 3: Donor complications.
Complication Comment n
Clavien 4b
Pulmonary embolism Reanimation with ICU admission with full recovery 1
Clavien 4a
Myocardial infarction NSTEMI with ICU admission 1
Aortical lesion life threatening intraoperative bleeding 1
Clavien 3b
Retroperitoneal haematoma Reoperation 7
Chylous leakage Reoperation 3
Hernia Reoperation (1 inguinal, 1 incisional) 2
Small bowel perforation Reoperation 2
Mechanical ileus Reoperation (1 ileum resection) 2
Testicular torsion Reoperation with orchiectomy 1
Benign prostatic hyperplasia with recurrent urinary retention Reoperation with TURP 1
Arterial lesion Renal arterial branch (intraoperative), internal iliac artery (reoperation) 2
Carotid dissection Reoperation 1
Clavien 3a
Pneumothorax Chest drain 5
Chylous leakage Percutaneous drainage 4
Pulmonary oedema ICU admission and loop diuretics 1
Clavien 2
Urinary tract infection 43
Wound infection 17
Pneumonia 14
Epididymitis Requiring antibiotics 5
Septicaemia Venous line associated 3
Other infections Requiring antibiotics 15
Acute hepatitis Drug related 1
Paralytic ileus Prolonged ileus > 2 days 6
Severe gastritis Gastroscopy 3
Haematoma Requiring blood transfusion 12
Allergic reaction 2 antibiotic associated, 3 unknown reasons 5
Thrombosis Right arm 1
Bronchospasm post-surgery Known asthma 2
Cardiac arrhythmia 1 atrial fibrillation, 1 AV re-entry tachycardia 2
Clavien 1
Urinary retention 28
Other genitourinary disorders 3 hydrocele, 1 macrohaematuria, 1 penis ulcer 5
Chylous leakage Without further intervention 7
Pneumothorax Without chest drain 6
Severe haematoma No blood transfusion or intervention 10
Secondary wound healing Bedside wound opening day 2 1
Severe vomitus ≥ 2 days 10
Intraoperative positioning related complication 6 rhabdomyolysis, 1 severe shoulder pain,
3 nerve lesion, 1 costal fracture
11
Anaesthesia related complication 1 teeth damage, 1 glottis lesion, 1 keratitis, 3 venous line related phlebitis 6
Allergic skin reaction No treatment 5
Severe skin emphysema After retroperitoneoscopic nephrectomy 1
Retained needle No further intervention as asymptomatic 1
Overall total n 254
AV = atrioventricular; ICU = intensive care unit; NSTEMI = non-ST elevation myocardial infarction; TURP = transurethral resection of the prostate
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the overall rate of all the different categories of complica-
tions (p = 0.24).
Discussion
During the study period, there was no perioperative mor-
tality in 1694 consecutive living donor nephrectomies.
Historically, not a single donor has died as a consequence
of the nephrectomy since the beginning of LKD in
Switzerland in 1966 [14]. In the literature the overall LKD
Table 1: Baseline characteristics.
data avail-
able
(n)
BMI (kg/m2), median (IQR) 1637 25.0 (22.8–27.8)
BMI 30–35 kg/m2, n (%) 168 (10.3)
BMI >35 kg/m2, n (%) 19 (1.2)
Age (years), median (range) 1649 52.3 (21.6–80.0)
21–30 years, n (%) 63 (3.8)
31–40 years, n (%) 238 (14.4)
41–50 years, n (%) 453 (27.5)
51–60 years, n (%) 508 (30.8)
61–70 years, n (%) 329 (20.0)
71–80 years, n (%) 58 (3.5)
Female (%) 1649 65.1%
Right kidney (%) 1252 30.9%
Creatinine (μmol/l), median
(IQR)
1620 67 (58–77)
GFR (ml/min/1.73m2), median
(IQR)
1620 115.5 (99.0–134.3)
Arterial hypertension (%) 1386 18.3%
BMI = body mass index; GFR = glomerular filtration rate; IQR = in-
terquartile range
Table 2: Surgical method.
n Frequency
Open nephrectomy 210 12.7%
Pararectal mini-incision nephrectomy 121 7.4%
Pure laparoscopy 208 12.6%
Hand assisted laparoscopic nephrectomy 569 34.5%
Retroperitoneoscopic 541 32.8%
Table 4: Odds ratios for Clavien ≥3 complications by age groups.
Age group Odds ratio 95% confi-
dence interval
p-value
<50 yrs Reference
50–60 yrs 0.81 0.32–2.06 0.816
60–70 yrs 1.64 0.70–3.82 0.26
>70 yrs 3.99 1.37–11.67 0.0197
Table 5: Odds ratios for urinary tract infection by age group.
Age group Odds ratio 95% confi-
dence interval
p-value
<50 yrs Reference
50–60 yrs 1.82 0.79–4.19 0.199
60–70 yrs 2.79 1.23–6.34 0.0154
>70 yrs 5.86 2.01–16.56 0.0027
Table 6: Odds ratio for urinary retention by age groups.
Age group Odds ratio 95% confidence
interval
p–value
<50 yrs Reference
50–60 yrs 1.08 0.40–2.92 0.88
60–70 yrs 1.30 0.46–3.68 0.62
>70 yrs 6.61 2.29–19.11 0.0017
specific mortality is known to be between 0.03% and
0.04% [11, 15]. Overall, there were 254 complications in
222 donors (13.5%) observed during the study period. This
complication rate is similar to those reported in the litera-
ture, with a rate of 7.9 to 20.9% [8, 16–19]. Severe postop-
erative complications (Clavien 3 and 4) were seen in 2.1%
of donors compared with 2.9% to 7.3% in previous publi-
cations [8, 17, 18]. We found a significant association be-
tween severe complications (Clavien 3 and 4) and donor
age (>70 years vs <50 years) and the laparoscopic surgical
approaches. Similar findings were reported by Lentine and
co-workers, who found a higher incidence of all grades
of complications with increasing age at donation (adjusted
OR 1.01, 95% CI 1.01–1.02) [17] and by the Norwegian
Registry [8], which showed a significant association be-
tween laparoscopic nephrectomy and major complications
with an OR of 2.01. This result might be explained by a
learning curve after introduction of the new laparoscopic
surgical techniques, as has been reported by several groups
[8, 20]. But after analysing the overall complication rates
by surgical technique, we could not find any difference be-
tween open and laparoscopic nephrectomy (p = 0.094).
Twenty donors needed a reoperation. The most common
reasons were bleeding complications (n = 8) and bowel
complications (n = 5). In 10 donors, the laparoscopic sur-
gical approach was converted to OLDN, in two of these
patients because of severe intraoperative bleeding. Mjoen
et al reported intraoperative bleeding complications in 14/
1022 donors, with necessary conversion to open surgery in
3/14 [8]; even fatal haemorrhage has occurred [21, 22].
Chylous leakage was observed in 13 donors (0.8%), three
of whom needed reoperation and four an intervention with
percutaneous drainage of the chyle, with our without a low
fat medium-chain triglyceride diet and octreotide applica-
tion for resolving of the chylous leakage. The highest rate
of chylous drainage after LDN in the literature was report-
ed by Capocasale et al., at 3.8% of donor [23]. The chylous
leakage in their series was solely observed in donors with
left sided LDN, which was also the case in our series. This
complication is left-side dependent because of the root of
the mesentery and the presence of the left ascending lum-
bar trunk in the area of surgical dissection. We could not
find a relation between the occurrence of chylous leakage
and nephrectomy techniques (open vs laparoscopic) (p =
0.31).
There are a large number of publications comparing the
complication rate of different kinds of surgical techniques.
In two large systematic reviews and one meta-analysis the
authors could not find a significant difference between
the different surgical techniques with regard to the overall
early intra- and perioperative complication rates [24–26].
These data suggest that there is no substantial difference
between the applied surgical techniques in terms of early
complication rate. In general, laparoscopic nephrectomy is
more often used nowadays because it is associated with
less pain after surgery, shorter hospital stay and faster re-
turn to work [27–29].
Donor obesity is always a concern, not only in terms of
onset of metabolic syndrome after kidney donation with
its risk of end-stage renal disease, but also in terms of pe-
rioperative complication rates. During past decades more
and more obese donors were accepted for donation [19].
In our study, we did not find an association between obese
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donors (BMI >30 kg/m2; 11.5% of the study population)
and early complications of any kind. Whether this holds
true for very obese donors (BMI >35 or >40 kg/m2) is un-
clear as only 1.2% of our study population had a BMI >35
kg/m2. Mjoen also found no association with periopera-
tive bleeding and/or intraoperative incidents in their 8.3%
obese donors with a BMI >30 kg/m2 [8]. O’Brien reported
an overall equal early complication rate in obese patients
(25.6% of their study population) in a series of 383 donor
nephrectomies, but a higher incidence of respiratory com-
plications in a subgroup analysis of patient with a BMI >40
kg/m2 [30]. Schold et al., in a large US registry study, did
not find any association between obesity and procedure-
related complications in more than 69 000 donor nephrec-
tomies [19]. These data are in contrast to the registry-based
studies from Friedman et al. and Patel et al., who reported a
higher incidence of donor complications in obese patients
with ORs of 1.76 and 1.92, respectively [16, 18]. Overall,
the available data and our experience suggest an acceptable
safety of nephrectomy in obese patient, with low levels of
severe early complications across all BMI categories, but
long-term surveillance of new onset of arterial hyperten-
sion or diabetes is mandatory when obese patients are ac-
cepted for donation.
Infectious diseases after donation were the most frequent
Grade 2 complication, with a high rate of clinical UTI
(2.6%). In contrast, Mjoen et al [8] found a much higher
incidence of UTI (10.1%). But in their study, donors were
systematically screened postoperatively with urine culture
for UTI without differentiation between asymptomatic
bacteriuria and clinical UTI. So there might be an overes-
timation of UTI in their study. We assume that the higher
rate of urinary retention observed in male elderly donors
is due to an underlying prostatic hyperplasia. We observed
some complications associated with intraoperative posi-
tioning of the donor in 0.7%, as well as anaesthesia-related
complication in 0.4% of donors. Data about the incidence
of such complications in living donor nephrectomy are
very rare in the literature, with only a few case reports
of rhabdomyolysis after donor nephrectomy [31, 32]; this
suggests an underreporting of such incidents.
Eighteen per cent of donors had a history of hypertension
at the time of donation, which is comparable to other reg-
istries [7, 8]. During the hospitalisation, new onset hyper-
tension was diagnosed in another 0.9% of donors. Previ-
ously published data from the SOL-DHR have shown that
kidney donation increases the risk of hypertension after
1 year 3.64-fold [33] underlining the importance of close
blood pressure surveillance after kidney donation.
The strengths of the current study are the prospective na-
ture, standardisation, consistency and completeness of the
data collected over 18 years on a nationwide basis, i.e., in-
cluding every single consecutive donor within one coun-
try and resulting in a high number of donors included in
the analysis. Data collection was very detailed and regu-
lar queries were made. In addition, each complication was
confirmed by the medical staff of the SOL-DHR. Underre-
porting was further minimised by including complications
reported to the SOL-DHR by the donors or their gener-
al practitioner. After confirmation these complication were
included in the analysis.
However, there are also several limitations. Despite the
very careful prospective collection of the complications on
a standardised questionnaire, there remains a risk of under-
reporting of early complications and a lack of systematic
review of donor charts and surgical reports. Secondly, the
low frequency of major complications and intraoperative
incidents limits multivariate analysis of several risk fac-
tors. Thirdly, there might be other risk factors not known
and therefore not collected specifically by the SOL-DHR.
However, patients had the possibility to mention any com-
plication as free text on the form. Up to now, no clear com-
plication or problem could be identified. Last, but not least,
caution is necessary in extrapolating the low complication
rates seen in our study to other cohorts without considering
a potentially overall lower risk profile of our Swiss donor
population.
In summary, our data confirm that living donor nephrecto-
my is a safe procedure with a low rate of major and minor
complications, independent of surgical technique. We did
not find a higher incidence of any complication in obese
donors, which supports the policy of acceptance of obese
individuals for donation. In contrast, we found a higher in-
cidence of severe complications (Clavien 3 and 4) and gen-
itourinary complications (UTI, urinary retention) in donors
aged >70 years. It is mandatory to carefully inform older
donors about their elevated perioperative risks. Further-
more, continuous prospective evaluation of donor com-
plications by donor registries is crucial, to improve peri-
and postoperative management and to detect any increase
in risks, as donors with more comorbidities are accepted
nowadays. Our results have prompted our Swiss working
group for living donors to renew the documents for donors`
general information accordingly.
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Appendix 1: Questionnaire for reporting surgi-
cal complications to the SOL-DHR
The questionnaire is available as a separate file at
https://smw.ch/en/article/doi/smw.2017.14497/
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